Forest Ray

Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.

Next month, participants in the research program will also lose access to past genetic counseling notes and won’t be able to schedule future appointments. 

Southern Research, MyOme, and Broad Clinical Labs will use $25 million in grants to provide genetic testing and counselling to up to 30,000 state residents.

Observation alone resulted in positive outcomes for MRD-negative patients, whereas MRD-positive individuals may still need adjuvant chemotherapy.

A quantitative continuous score identified patients with a TROP2 biomarker likely to respond to the antibody-drug conjugate, a study presented at WCLC showed. 

Patients will be offered germline genetic testing after an assessment that includes genetic, lifestyle, and other clinical risk factor analysis.

The biomarker p-tau 217 best correlated with other established signs of Alzheimer's disease in a head-to-head study evaluating six blood-based assays.

The UK startup hopes to quickly select a lead ASO therapy to advance to clinical studies for a rare brain disorder next year, as it eyes the UK and US markets.

Project Africa GRADIENT aims to gather and analyze pharmacogenetic data specific to African populations with funding from Novartis and GlaxoSmithKline.

The Australian firm seeks to validate its DiGAP platform in a clinical study by categorizing ALS patients according to their most affected biological pathways.